This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Massimo Mariani: Innovator in Antigen Stability
Introduction
Massimo Mariani is a notable inventor based in Siena, Italy. He has made significant contributions to the field of biotechnology, particularly in enhancing the stability of antigens. His innovative work has implications for vaccine development and other medical applications.
Latest Patents
Massimo Mariani holds a patent titled "Elimination of disulphide bond formation of cysteine-containing antigens enhances antigen stability." This invention provides variant forms of cysteine-containing antigens with a point mutation that replaces, deletes, or modifies the cysteine residue. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Mariani is currently associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical and biotechnology sector. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to advancements in vaccine technology and antigen research.
Collaborations
Throughout his career, Massimo has collaborated with esteemed colleagues such as Fabio Bagnoli and Fabiana Falugi. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.
Conclusion
Massimo Mariani's work in antigen stability represents a significant advancement in biotechnology. His innovative patent and collaborations with other experts highlight his commitment to improving medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile